HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

CRQILGQLQPSLQTG Gag(57-71) H-2d transgenic mouse epitope
 KQIMKQLQPALQTGT Gag(58-72) human epitope
 KQIiKQLQPALQTGT Gag(58-72) subtype-specific non-susceptible form
 crQIlgQLQPALQTGT Gag(58-72) subtype-specific susceptible form
 KQIigQLQPAiQTGs Gag(58-72) subtype-specific non-susceptible form
 cqQImeQLQsALkTse Gag(58-72) subtype-specific non-susceptible form
    LGQLQPSLQTGSEELRSLYN Gag(61-80) human epitope
      QLQPSLQTGS Gag(63-72) A*02 human epitope
      QLQPSLQTGSEELR Gag(63-76) human epitope
      QLQPSLQTGSEELRSLY Gag(63-79) human epitope
            QTGSEELRSLYNTVATLYCVHQRIE Gag(69-93) A2 human epitope
             TGTEELRSLYNTVATLY Gag(70-86) C*14 human epitope
             TGSEELRSLYNTVATLY Gag(70-86) human epitope
             TGSEELRSLYNTVATLY Gag(70-86) human epitope
              GSEELRSLY Gag(71-79) A*01 human epitope
              GSEELRSLY Gag(71-79) A*01 human epitope
              GSEELkSLY Gag(71-79)
              GSEELRSLf Gag(71-79)
              GSEELRSLY Gag(71-79) A*01 human epitope
              GSEELkSLY Gag(71-79) escape documented in this paper; observed variant
              GSaELRSLY Gag(71-79) escape documented in this paper; observed variant
              GSEELRSLf Gag(71-79) escape documented in this paper; observed variant
              GSEELRSLY Gag(71-79) A*01 human epitope
              GSEELRSLY Gag(71-79) A*01 human epitope
              GSEELRSLf Gag(71-79) escape documented in this paper
              GSEELRSLc Gag(71-79) inferred escape
              GSEELRSLY Gag(71-79) A*01 epitope
              GSEELKSLY Gag(71-79) A*01 human epitope
              GSEELrSLY Gag(71-79) susceptible form
              GSEELRSLY Gag(71-79) A*01 human epitope
              GTEELRSLY Gag(71-79) A*01:01 human epitope
              GTEELRSLY Gag(71-79) A*01:01 human epitope
              GTEELRSLf Gag(71-79) diminished HLA binding or increased off-rate; escape documented in this paper
              GSEELRSLY Gag(71-79) A*01:01 human epitope
              GSEEikSLY Gag(71-79) diminished HLA binding or increased off-rate; escape documented in this paper
              GSEELRSLY Gag(71-79) A*01:01 human epitope
              GSEELRSLY Gag(71-79) A*01:01, B*57 human epitope
              GSEELRSLY Gag(71-79) A1 human epitope
              GSEELRSLY Gag(71-79) A1 human epitope
              GSEELRSLY Gag(71-79) A1 human epitope
              GSEELRSLY Gag(71-79) A1 epitope
              GSEELRSLY Gag(71-79) A1 human epitope
              GtEgikSLh Gag(71-79) observed variant
              GSEELRSLY Gag(71-79) A1 human epitope
              GSEELRSLY Gag(71-79) A1 human epitope
              GSEELRSLY Gag(71-79) A1 human epitope
              GSEELRSLY Gag(71-79) A1 human epitope
              GSEELRSLY Gag(71-79) B*07 human epitope
              GSEELRSLY Gag(71-79) C*14 human epitope
              GSEELRSLY Gag(71-79) human epitope
              GTEELRSLY Gag(71-79) human epitope
              GTEELKSLY Gag(71-79) human epitope
              GSEELRSLYNTVATL Gag(71-85) human epitope
              GSEELRSLYNTVATL Gag(71-85) human epitope
              GSEELRSLYNTVATLYCVHQ Gag(71-90) human epitope
              GSEELRSLYNTVATLYCVHQ Gag(71-90) human epitope
                EELRSLYNT Gag(73-81) human epitope
                EELRSLYNTV Gag(73-82) B*40:06 human epitope
                EELRSLYNTVATLYC Gag(73-87) A2 human epitope
                EELKSLFNTIAVLWCVHQ Gag(73-90) human epitope
                EELKSLFNTvAVLWCVHk Gag(73-90) observed variant
                EELKSLFNTvAVLWCVHQ Gag(73-90) observed variant
                EELKSLFNTvAVLcCVHQ Gag(73-90) observed variant
                EELKpLFNTvAVLcCVHQ Gag(73-90) observed variant
                EELRSLYNTVATLYCVHQ Gag(73-90) human epitope
                 ELRSLYNTV Gag(74-82) A*24 human epitope
                 ELRSLYNTV Gag(74-82) B*08 human epitope
                 ELRSLYNTV Gag(74-82) B*08 human epitope
                 ELRSLYNTV Gag(74-82) B*08 epitope
                 ELKSLYNTV Gag(74-82) B*08 human epitope
                 ELrSLYNTV Gag(74-82) susceptible form
                 ELRSLYNTV Gag(74-82) B*08 human epitope
                 ELRSLYNTi Gag(74-82) observed variant
                 ELRSLfNTi Gag(74-82) observed variant
                 ELRSLcNTi Gag(74-82) observed variant
                 ELRSLYNai Gag(74-82) observed variant
                 ELRSLYNTV Gag(74-82) B*08 human epitope
                 ELRSLYNTV Gag(74-82) B*08:01 human epitope
                 ELRSLYNTV Gag(74-82) B*08:01 human epitope
                 ELRSLYNTV Gag(74-82) B*08:01 human epitope
                 ELRSLYNTV Gag(74-82) B*40 human epitope
                 ELRSLYNTV Gag(74-82) B*52 human epitope
                 ELRSLYNTV Gag(74-82) B8 human epitope
                 ELRSLYNTV Gag(74-82) B8 human epitope
                 ELkSLYNTV Gag(74-82) observed variant
                 ELkSLYNTi Gag(74-82) inferred escape
                 ELkSLfNTV Gag(74-82) observed variant
                 ELKSLyNTV Gag(74-82) reversion
                 ELRSLYNTV Gag(74-82) B8 human epitope
                 ELRSLYNTV Gag(74-82) B8 human epitope
                 ELRSLYNTV Gag(74-82) B8 human epitope
                 ELRSLYNTV Gag(74-82) B8 human epitope
                 ELRSLYNTV Gag(74-82) B8 human epitope
                 ELRSLYNTV Gag(74-82) B8 epitope
                 ELRSLYNTV Gag(74-82) B8 human epitope
                 gikSLhNTV Gag(74-82) observed variant
                 ELKSLFNTI Gag(74-82) B8 human epitope
                 ELRSLYNTV Gag(74-82) C*06 human epitope
                 ELRSLYNTV Gag(74-82) human epitope
                 ELRSLYNTV Gag(74-82) human epitope
                 ELRSLYNTVA Gag(74-83) A2 human epitope
                 ELKSLYNTVATLYCV Gag(74-88) human epitope
                 ELrSLfNTVATLYCV Gag(74-88) subtype-specific susceptible form
                 eELrSLYNTVATLYCV Gag(74-88) subtype-specific susceptible form
                 ELrSLYNTVATLYCV Gag(74-88) subtype-specific susceptible form
                 LKSLfNTVATLYCVH Gag(74-88) subtype-specific susceptible form
                   KSLYNTVCV Gag(76-84) H-2Db mouse epitope
                   RSLYNTVATLY Gag(76-86) A*02 human epitope
                   RSLYNTVATLY Gag(76-86) A*02:01, A*30:02 human epitope
                   RSLYNTiATLY Gag(76-86) diminished response; escape documented in this paper
                   RSLYNTVAvLY Gag(76-86) diminished response; escape documented in this paper
                   RSLYNTiAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
                   RSLfNTiATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
                   RSLfNTVATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
                   RSLfNTVAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
                   RSLfNTiAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
                   kSLYNTVATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response
                   kSLYNTVAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
                   kSLYNTiATLY Gag(76-86) diminished response; escape documented in this paper
                   kSLYNTiAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
                   kSLfNTVATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
                   kSLfNTiATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
                   kSLfNTVAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
                   kSLfNTiAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
                   RSLYNTVATLY Gag(76-86) A*29 human epitope
                   RSLYNTVATLY Gag(76-86) A*30 human epitope
                   RSLfNTVATLY Gag(76-86) observed variant
                   kSLYNTVATLY Gag(76-86) literature escape
                   RSLYNTVAvLY Gag(76-86) observed variant
                   RSLYNTiATLY Gag(76-86) observed variant
                   RSLYNTVvTLY Gag(76-86) observed variant
                   RSLYNTVATLY Gag(76-86) A*30 human epitope
                   RSLYNTVATLY Gag(76-86) A30 human epitope
                   RSLYNTVATLY Gag(76-86) A30 human epitope
                   RSLYNTVATLY Gag(76-86) A30 human epitope
                   RSLYNTVATLY Gag(76-86) A30 human epitope
                   RSLYNTATLY Gag(76-86) A30 human epitope
                   RSLYNTVAVLY Gag(76-86) A30 human epitope
                   RSLYNTVATLY Gag(76-86) A30 human epitope
                   RSLYNTVATLY Gag(76-86) A30 human epitope
                   RSLYNTVATLY Gag(76-86) A30 epitope
                   RSLYNTVATLY Gag(76-86) A*30:02 human epitope
                   RSLYNTVATLY Gag(76-86) A*30:02 human epitope
                   RSLYNTVATLY Gag(76-86) A*30:02 human epitope
                   RLSYNTVATLY Gag(76-86) A*30:02 human epitope
                   RSLYNTVATLY Gag(76-86) A*30:02 human epitope
                   RSLYNTVATLY Gag(76-86) A*30:02 human, macaque epitope
                   RSLYNTVATLc Gag(76-86) escape documented in this paper
                   kSLfNTVATLc Gag(76-86) escape documented in this paper
                   RSLfNTiATLf Gag(76-86) escape documented in this paper
                   RSLYNTVATLY Gag(76-86) A*30:02 human epitope
                   RSLYNTVATLY Gag(76-86) A*30:02 human epitope
                   RSLYNTVATLY Gag(76-86) A*30:02 human epitope
                   RSLYNTVATLY Gag(76-86) A*30:02 human epitope
                   kSLYNTVATLY Gag(76-86) inferred escape
                   kSLYNTVAvLY Gag(76-86) inferred escape
                   RSLYNTVATLY Gag(76-86) A*30:02 human epitope
                   RSLYNTVATLY Gag(76-86) B57, B58, B63 human epitope
                   RSLYNTVATLY Gag(76-86) B*58 human epitope
                   RSLYNTVATLY Gag(76-86) B*63 human epitope
                   RSLYNTVATLY Gag(76-86) C*03 human epitope
                   RSLFNTVATLY Gag(76-86) human epitope
                   RSLyNTVATLY Gag(76-86) observed variant
                   RSLYNTVATLY Gag(76-86) human epitope
                   KSLYNTVVTLWCVHQ Gag(76-90) human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLFNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLFNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLfNTiAvL Gag(77-85) escape documented in this paper
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVAvL Gag(77-85) subtype-specific susceptible form
                    SLfNTVATL Gag(77-85) subtype-specific susceptible form
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLfNTVAvL Gag(77-85) diminished response
                    SLvNTiATL Gag(77-85) diminished response
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTiATL Gag(77-85) susceptible form
                    SLfNTVATL Gag(77-85) susceptible form
                    SLfNTVAvL Gag(77-85) susceptible form
                    SLfNTiAvL Gag(77-85) susceptible form
                    SLhNTVATL Gag(77-85) escape documented in this paper; TCR related mutation
                    SLYaaaAaL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTIATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVAvL Gag(77-85) HLA association; processing
                    SLfNTVATL Gag(77-85) HLA association; processing
                    SLYNTiATL Gag(77-85) HLA association; processing
                    SLYNTiAvL Gag(77-85) HLA association; processing
                    SLfNTiATL Gag(77-85) HLA association; processing
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLFNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTiATL Gag(77-85) susceptible form
                    SLfNTiATL Gag(77-85) diminished response; escape documented in this paper
                    SLYNaiATL Gag(77-85) inferred escape
                    SLcNTiATL Gag(77-85) inferred escape
                    SLYNTVATL Gag(77-85) A*02 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVAvL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper; literature escape; susceptible form
                    {k}SLfNTVAvL Gag(77-85) literature escape
                    {k}SLfNTiAvL Gag(77-85) literature escape
                    {k}SLYNTVATL Gag(77-85) literature escape
                    SLfNTVATL Gag(77-85) escape documented in this paper; literature escape; susceptible form
                    {k}SLfNTiATL Gag(77-85) literature escape
                    {k}SLfNTVATL Gag(77-85) literature escape
                    SLYNTiATL Gag(77-85) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper; literature escape; susceptible form
                    SLYNTiAvL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper; literature escape; susceptible form
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 transgenic mouse epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLhNaVAvL Gag(77-85) escape documented in this paper
                    SLfNTVATL Gag(77-85) escape documented in this paper
                    SLYNTiAvL Gag(77-85) susceptible form
                    SLhNTVATL Gag(77-85) escape documented in this paper
                    SLlNTVATL Gag(77-85) observed variant
                    SLYNTVAvL Gag(77-85) observed variant
                    SLYNTiATL Gag(77-85) observed variant
                    SLsNTiATL Gag(77-85) observed variant
                    SLfNTVAvL Gag(77-85) observed variant
                    SLYNTVATL Gag(77-85) A*02:01 humanized mouse epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTiAvL Gag(77-85) literature escape
                    SLfNTVATL Gag(77-85) literature escape
                    SLYNTiATL Gag(77-85) literature escape
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTiATL Gag(77-85) escape documented in this paper; processing; susceptible form
                    SvYNTVATL Gag(77-85) escape documented in this paper; processing; susceptible form
                    SLYNlVATL Gag(77-85) escape documented in this paper; processing; susceptible form
                    SLfNTVAvL Gag(77-85) escape documented in this paper; processing; susceptible form
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLfNTVATL Gag(77-85) susceptible form
                    SLYNTiATL Gag(77-85) susceptible form
                    SLfNTiATL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVVTL Gag(77-85) A*02:01 human epitope
                    SLYNTVaTL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLfNTVATL Gag(77-85) escape documented in this paper; susceptible form
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    {l}SLYNTVAvL Gag(77-85) observed variant
                    {l}SLYNTVATL Gag(77-85) susceptible form
                    {m}SLYNTVATL Gag(77-85) observed variant
                    SLYNaVAvL Gag(77-85) non-susceptible form
                    {m}SLYNTVAvL Gag(77-85) observed variant
                    {i}SLYNTVATL Gag(77-85) observed variant
                    aLYNTVAvL Gag(77-85) observed variant
                    aLfNTVATL Gag(77-85) observed variant
                    SLYNiVATL Gag(77-85) observed variant
                    {q}SLYNTVAvL Gag(77-85) observed variant
                    {q}SLYNTVATL Gag(77-85) observed variant
                    {v}SLYNTVATL Gag(77-85) observed variant
                    SLYNcVATL Gag(77-85) observed variant
                    {t}SLYNTVATL Gag(77-85) observed variant
                    SLYNTiAsL Gag(77-85) observed variant
                    SLYNsVAvL Gag(77-85) observed variant
                    SLYNciATL Gag(77-85) observed variant
                    aLYNTVATL Gag(77-85) observed variant
                    SLYNTVAvL Gag(77-85) observed variant
                    SLYNlVATL Gag(77-85) observed variant
                    {t}SLYNTVAvL Gag(77-85) observed variant
                    {v}SLYNTVAvL Gag(77-85) observed variant
                    SLYNTiAvL Gag(77-85) observed variant
                    {l}SLYNlVATL Gag(77-85) observed variant
                    {n}SLYNTVAvL Gag(77-85) observed variant
                    {f}SLYNTVATL Gag(77-85) observed variant
                    SLYNTiATL Gag(77-85) observed variant
                    SLYNTVAcL Gag(77-85) non-susceptible form
                    {l}SLYNTVAcL Gag(77-85) observed variant
                    {l}SLYNTVATL{w} Gag(77-85) observed variant
                    {c}SLYNTVATL Gag(77-85) observed variant
                    {k}SLYNTVATL Gag(77-85) observed variant
                    SLYNcVAcL Gag(77-85) non-susceptible form
                    SLYNTcAvL Gag(77-85) observed variant
                    SLYNTVAsL Gag(77-85) observed variant
                    SLfNTVATL Gag(77-85) observed variant
                    SLYNlVAvL Gag(77-85) observed variant
                    SLYNTVAaL Gag(77-85) observed variant
                    {m}SLYNlVATL Gag(77-85) observed variant
                    {v}SLYNlVATL Gag(77-85) observed variant
                    {h}SLYNTVATL Gag(77-85) observed variant
                    {a}SLYNTVATL Gag(77-85) observed variant
                    SLYNTVATL{c} Gag(77-85) observed variant
                    SLYNTVATL{f} Gag(77-85) observed variant
                    {v}SLYNTVATL{w} Gag(77-85) observed variant
                    {m}SLYNTVATL{w} Gag(77-85) observed variant
                    {w}SLYNTVATL Gag(77-85) observed variant
                    {s}SLYNTVATL Gag(77-85) observed variant
                    {n}SLYNTVATL Gag(77-85) observed variant
                    {a}aLYNTVATL Gag(77-85) observed variant
                    {l}aLYNTVATL Gag(77-85) observed variant
                    {l}SLYsTVATL Gag(77-85) observed variant
                    {c}SLYNTVAvL Gag(77-85) observed variant
                    {s}SLYNTVAvL Gag(77-85) observed variant
                    {v}SLYNTVAsL Gag(77-85) observed variant
                    {l}SLYNTVAaL Gag(77-85) observed variant
                    {v}SLYNTVAaL Gag(77-85) observed variant
                    SLYNTVAvL{w} Gag(77-85) observed variant
                    SLYNTVAvL{s} Gag(77-85) observed variant
                    SLYNTVAvL{r} Gag(77-85) observed variant
                    SLYNTVATL{w} Gag(77-85) observed variant
                    SLYNTVATm Gag(77-85) observed variant
                    aLYNTVAaL Gag(77-85) observed variant
                    aLYNTVAsL Gag(77-85) observed variant
                    SLYNaVATL Gag(77-85) observed variant
                    SLYNsVATL Gag(77-85) observed variant
                    SLYNvVATL Gag(77-85) observed variant
                    SLYNrVATL Gag(77-85) observed variant
                    SLYNlVAsL Gag(77-85) observed variant
                    SLYNvVAsL Gag(77-85) observed variant
                    gLYNTVAvL Gag(77-85) observed variant
                    cLYNTVAvL Gag(77-85) observed variant
                    gLYNTVATL Gag(77-85) observed variant
                    mLYNTVATL Gag(77-85) observed variant
                    SLYmTVATL Gag(77-85) observed variant
                    SLYrTVATL Gag(77-85) observed variant
                    SLYgTVAvL Gag(77-85) observed variant
                    SLYsTVAvL Gag(77-85) observed variant
                    SLYcTVAvL Gag(77-85) observed variant
                    SLYgTVAsL Gag(77-85) observed variant
                    SLYgTVgTL Gag(77-85) observed variant
                    SLYNTVgTL Gag(77-85) observed variant
                    SLYNTVsTL Gag(77-85) observed variant
                    SLYNTcATL Gag(77-85) observed variant
                    SiYNTVATL Gag(77-85) observed variant
                    StYNTVATL Gag(77-85) observed variant
                    ScYNTVATL Gag(77-85) observed variant
                    SvYNTVATL Gag(77-85) observed variant
                    avYNTVATL Gag(77-85) observed variant
                    vLYNTVATL Gag(77-85) observed variant
                    tLYNTVATL Gag(77-85) observed variant
                    rLYNTVATL Gag(77-85) observed variant
                    wLYNTVATL Gag(77-85) observed variant
                    qLYNTVATL Gag(77-85) observed variant
                    SLYyTVATL Gag(77-85) observed variant
                    SLYvTVATL Gag(77-85) observed variant
                    SLYfTVATL Gag(77-85) observed variant
                    SLYsTVATL Gag(77-85) observed variant
                    SLYlTVATL Gag(77-85) observed variant
                    SLYaTVATL Gag(77-85) observed variant
                    SLYtTVATL Gag(77-85) observed variant
                    SLYgaVATL Gag(77-85) observed variant
                    SLYyTVAvL Gag(77-85) observed variant
                    SLYslVATL Gag(77-85) observed variant
                    SLYNvlATL Gag(77-85) observed variant
                    SLYNTtATL Gag(77-85) observed variant
                    SLYNTlATL Gag(77-85) observed variant
                    SLYNTVgvL Gag(77-85) observed variant
                    SLYNTVAiL Gag(77-85) observed variant
                    SLrNTVATL Gag(77-85) observed variant
                    SLvNTVATL Gag(77-85) observed variant
                    SLwNTVATL Gag(77-85) observed variant
                    SLYNTVATv Gag(77-85) observed variant
                    SLYNTVATi Gag(77-85) observed variant
                    {y}SLYNTVATL Gag(77-85) observed variant
                    SLYNTVATL{l} Gag(77-85) observed variant
                    {l}SLYNvVATL Gag(77-85) observed variant
                    {c}SLYNlVATL Gag(77-85) observed variant
                    {c}SLYNvVATL Gag(77-85) observed variant
                    {g}SLYNTVATL Gag(77-85) observed variant
                    {e}SLYNTVATL Gag(77-85) observed variant
                    {l}gLYNTVATL Gag(77-85) observed variant
                    SLYNTVAvL{l} Gag(77-85) observed variant
                    {k}SvYNTVATL Gag(77-85) observed variant
                    {v}gLYNTVATL Gag(77-85) observed variant
                    SLYNTVATL{a} Gag(77-85) observed variant
                    {v}SLYaTVATL Gag(77-85) observed variant
                    SLYgTVATL{m} Gag(77-85) observed variant
                    SLYNTVAvL{a} Gag(77-85) observed variant
                    SLYgTVATL{a} Gag(77-85) observed variant
                    SLYNvVATL{w} Gag(77-85) observed variant
                    aLYNTVATL{l} Gag(77-85) observed variant
                    SLYNTVAcL{l} Gag(77-85) observed variant
                    SLYNTVATL{m} Gag(77-85) observed variant
                    {a}SLYNTVAvL Gag(77-85) observed variant
                    {v}SLYNTVAcL Gag(77-85) observed variant
                    SLYcTVATL Gag(77-85) non-susceptible form
                    SLYgTVATL Gag(77-85) observed variant
                    SLYhTVATL Gag(77-85) observed variant
                    SLYhlVATL Gag(77-85) observed variant
                    SLYNmVATL Gag(77-85) observed variant
                    SLYNTVvTL Gag(77-85) observed variant
                    cLYNTVATL Gag(77-85) observed variant
                    {v}SLYNTVATL{l} Gag(77-85) observed variant
                    {c}aLYNTVATL Gag(77-85) observed variant
                    {q}aLYNTVATL Gag(77-85) observed variant
                    {a}SLYNTVATv Gag(77-85) observed variant
                    SLYNTVAvL{m} Gag(77-85) observed variant
                    {v}SvYNTVATL Gag(77-85) observed variant
                    SLYgTVcTL Gag(77-85) observed variant
                    SLYNTVATL{r} Gag(77-85) observed variant
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLfNTVATL Gag(77-85) diminished HLA binding or increased off-rate
                    SLYNTVAvL Gag(77-85) diminished HLA binding or increased off-rate
                    SLYNTiATL Gag(77-85) diminished HLA binding or increased off-rate
                    SLfNTiAvL Gag(77-85) diminished HLA binding or increased off-rate; literature escape
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLFNTVATL Gag(77-85) A*02:01 human epitope
                    SLFNTVAAL Gag(77-85) diminished response
                    SLFNTVATP Gag(77-85) diminished response
                    SLFSTVATL Gag(77-85) observed variant
                    SLFNTIATL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 humanized mouse epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLfNTVATL Gag(77-85) subtype-specific susceptible form
                    SLYNTiaTL Gag(77-85) subtype-specific susceptible form
                    SLYNIiAvL Gag(77-85) subtype-specific susceptible form
                    SLYNTVAvL Gag(77-85) subtype-specific susceptible form
                    SLfNTiATL Gag(77-85) subtype-specific susceptible form
                    SLfNTiAvL Gag(77-85) subtype-specific susceptible form
                    SLfNTVAvL Gag(77-85) subtype-specific susceptible form
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTIATL Gag(77-85) A*02:01 human epitope
                    SLYNTIAvL Gag(77-85) susceptible form
                    SLYNTvATL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) A*02:01 human, transgenic mouse epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 transgenic mouse epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 humanized mouse epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 mouse epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 mouse epitope
                    SLYNTVATL Gag(77-85) A*02:01 epitope
                    SLfNTVATL Gag(77-85) susceptible form
                    SLYNTiATL Gag(77-85) susceptible form
                    SLYNTVAvL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 mouse epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLFNTVATL Gag(77-85) A*02:01 human epitope
                    SLyNTVATL Gag(77-85) subtype-specific non-susceptible form
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLfNTiATL Gag(77-85) subtype-specific non-susceptible form; subtype-specific susceptible form
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 mouse epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human, transgenic mouse epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLFNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVAAL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLfNaiAvL Gag(77-85) subtype-specific non-susceptible form
                    SLfNTVATL Gag(77-85) subtype-specific non-susceptible form
                    SLYNTiATL Gag(77-85) subtype-specific susceptible form
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLfNTVATL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper
                    SLfNTVAvL Gag(77-85) escape documented in this paper; TCR related mutation
                    SLYNTVvTL Gag(77-85) inferred escape
                    SLfNTiATL Gag(77-85) inferred escape
                    SLYNTiAvL Gag(77-85) escape documented in this paper; TCR related mutation
                    SLhNTVAvL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper
                    SLYNTVAvL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01 human epitope
                    SLYNTVATL Gag(77-85) A*02:01, A*02:14 human epitope
                    SLYNTVATL Gag(77-85) A*02:02 human epitope
                    SLYNTVATL Gag(77-85) A*02:02 human epitope
                    SLYNTVATL Gag(77-85) A*02:02 human epitope
                    SLYNTVATL Gag(77-85) A*02:02, A2 human epitope
                    SLfNTVATL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) A*02:05 human epitope
                    SLYNTVATL Gag(77-85) A2 human, transgenic mouse epitope
                    SLfNTVATL Gag(77-85) susceptible form
                    SLYNlVATL Gag(77-85) susceptible form
                    SLfNlVATL Gag(77-85) susceptible form
                    SiYNlVATL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLFNTVATL Gag(77-85) A2 human epitope
                    SLyNTVATL Gag(77-85) susceptible form
                    SLYNTIATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLfNTVATL Gag(77-85) escape documented in this paper
                    SLYNTVAvL Gag(77-85) escape documented in this paper
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 mouse epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human, transgenic mouse epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTAVTL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLfNTVATL Gag(77-85) escape documented in this paper; susceptible form; TCR related mutation
                    SLYNTiATL Gag(77-85) escape documented in this paper
                    SLYNTiAvL Gag(77-85) escape documented in this paper; non-susceptible form; susceptible form; TCR related mutation
                    SLfNTiATL Gag(77-85) escape documented in this paper; non-susceptible form; susceptible form; TCR related mutation
                    SLYNlVAvL Gag(77-85) escape documented in this paper; non-susceptible form; TCR related mutation
                    SLYNTVAaL Gag(77-85) observed variant
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLfNTVcvi Gag(77-85) diminished response; escape documented in this paper; subtype-specific non-susceptible form; TCR related mutation
                    SLfNTVATL Gag(77-85) diminished response; escape documented in this paper; subtype-specific non-susceptible form; TCR related mutation
                    SLfNaVATL Gag(77-85) diminished response; escape documented in this paper; subtype-specific non-susceptible form; TCR related mutation
                    SLaNTVATL Gag(77-85) diminished response; escape documented in this paper; TCR related mutation
                    SLYaTVATL Gag(77-85) diminished response; escape documented in this paper; TCR related mutation
                    SLYNaVATL Gag(77-85) diminished response; escape documented in this paper; TCR related mutation
                    SLYNTaATL Gag(77-85) susceptible form
                    SLYNTVAaL Gag(77-85) diminished response; escape documented in this paper; TCR related mutation
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLFNTVATL Gag(77-85) A2 human epitope
                    SLyNTVATL Gag(77-85) escape documented in this paper
                    SLyNaVATL Gag(77-85) escape documented in this paper
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 transgenic mouse epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLfNTVATL Gag(77-85) observed variant
                    SLYNTiATL Gag(77-85) observed variant
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLfNTiATL Gag(77-85) escape documented in this paper
                    SLfNTiAaL Gag(77-85) observed variant
                    SLfNTVAvL Gag(77-85) escape documented in this paper
                    SLfsTVAvL Gag(77-85) observed variant
                    SLfNTVAvp Gag(77-85) observed variant
                    SLfNTiAvL Gag(77-85) observed variant
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLfNTVATL Gag(77-85) susceptible form
                    SLYNTiATL Gag(77-85) susceptible form
                    SLYNTVAvL Gag(77-85) susceptible form
                    SLYNaVATL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTiATL Gag(77-85) susceptible form
                    SLYNTiAvL Gag(77-85) susceptible form
                    SLYNTVAvL Gag(77-85) susceptible form
                    SLfNTVATL Gag(77-85) susceptible form
                    SLfNTiAvL Gag(77-85) susceptible form
                    SLfNTVAvL Gag(77-85) susceptible form
                    SLfNTiATL Gag(77-85) susceptible form
                    SLYNsVATL Gag(77-85) susceptible form
                    SLYqTVATL Gag(77-85) susceptible form
                    SLYlTVATL Gag(77-85) susceptible form
                    aLYNTVATL Gag(77-85) susceptible form
                    SLaNTVATL Gag(77-85) non-susceptible form
                    SLYaTVATL Gag(77-85) non-susceptible form
                    SLYNTaATL Gag(77-85) diminished response
                    SLYNTVAaL Gag(77-85) diminished response
                    aLYNTaAaL Gag(77-85) non-susceptible form
                    SLYNvVATL Gag(77-85) non-susceptible form
                    SLYNlVAvL Gag(77-85) escape documented in this paper; TCR related mutation
                    SLYNlVAvL Gag(77-85) escape documented in this paper; TCR related mutation
                    SLYNaVATL Gag(77-85) escape documented in this paper; TCR related mutation
                    SLYNaiATL Gag(77-85) escape documented in this paper; TCR related mutation
                    SLYNlVAvL Gag(77-85) escape documented in this paper; TCR related mutation
                    SLYNTVATL Gag(77-85) A2 human, mouse epitope
                    SLYNTVAaL Gag(77-85) susceptible form
                    lLYNTVATL Gag(77-85) susceptible form
                    SLYNTVAsL Gag(77-85) susceptible form
                    SLYNTpATL Gag(77-85) susceptible form
                    lLYNTVAaL Gag(77-85) susceptible form
                    lLYNTVAsL Gag(77-85) susceptible form
                    lLYNTVlTL Gag(77-85) susceptible form
                    SLYNTsAaL Gag(77-85) susceptible form
                    lLYNTpATL Gag(77-85) susceptible form
                    SLYNTpAaL Gag(77-85) susceptible form
                    SLYNTpAsL Gag(77-85) susceptible form
                    SLhNwslaL Gag(77-85) susceptible form
                    SLwNwplaL Gag(77-85) susceptible form
                    SLwNwplsL Gag(77-85) susceptible form
                    SLhNwplaL Gag(77-85) susceptible form
                    SLhNwplsL Gag(77-85) susceptible form
                    lLwNTslaL Gag(77-85) susceptible form
                    lLwNwslaL Gag(77-85) susceptible form
                    lLwNwslsL Gag(77-85) susceptible form
                    lLwNwplaL Gag(77-85) susceptible form
                    lLhNwslaL Gag(77-85) susceptible form
                    lLhNwplsL Gag(77-85) susceptible form
                    SLfNTVATL Gag(77-85) escape documented in this paper; susceptible form
                    SLfNTVAvL Gag(77-85) diminished response; escape documented in this paper
                    SLfNTiAvL Gag(77-85) escape documented in this paper; susceptible form
                    SLYNTiATL Gag(77-85) diminished response; susceptible form
                    SLYNTiAvL Gag(77-85) diminished response; susceptible form
                    SvYNTVATL Gag(77-85) diminished response; susceptible form
                    SLYNTVAvL Gag(77-85) diminished response; susceptible form
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTiATL Gag(77-85) non-susceptible form; susceptible form
                    SLYNTVAvL Gag(77-85) observed variant
                    SLfNTVAvL Gag(77-85) escape documented in this paper
                    SLfNTVATL Gag(77-85) diminished HLA binding or increased off-rate; susceptible form
                    SLfNTiATL Gag(77-85) diminished response
                    SLfNTiAvL Gag(77-85) escape documented in this paper; TCR related mutation
                    SLhNaVAvL Gag(77-85) susceptible form
                    SLYNTiAvL Gag(77-85) diminished response
                    SLYNTiAiL Gag(77-85) observed variant
                    SLfNTVATv Gag(77-85) susceptible form
                    SLYNaVATL Gag(77-85) susceptible form
                    SLYNlVAvL Gag(77-85) diminished HLA binding or increased off-rate
                    SLYNTVAif Gag(77-85) diminished HLA binding or increased off-rate
                    SLfNaVATL Gag(77-85) reversion; susceptible form
                    SLfNaVAvL Gag(77-85) susceptible form
                    SLfNmVATL Gag(77-85) susceptible form
                    SLYNTVsTL Gag(77-85) susceptible form
                    SLYNTitvL Gag(77-85) susceptible form
                    SLYNTisvL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLFNTVATL Gag(77-85) A2 human epitope
                    SLYNTVAVL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVAvL Gag(77-85) diminished response
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLfNTVATL Gag(77-85) observed variant
                    SLYNTVAvL Gag(77-85) observed variant
                    SLYNTVATi Gag(77-85) observed variant
                    SLfNTVATi Gag(77-85) observed variant
                    SLnNaiAvL Gag(77-85) observed variant
                    SvYNTVATL Gag(77-85) observed variant
                    SLFNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 transgenic mouse epitope
                    SLYNTVATL Gag(77-85) A2 humanized mouse epitope
                    SLYNTVATL Gag(77-85) A2 epitope
                    SLFNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLfNTVATL Gag(77-85) subtype-specific susceptible form
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 transgenic mouse epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLfNTVATL Gag(77-85) observed variant
                    SLfNTVAvL Gag(77-85) diminished HLA binding or increased off-rate
                    SLsNTVATL Gag(77-85) diminished HLA binding or increased off-rate
                    SsfNTVATL Gag(77-85) observed variant
                    SLlNTVATL Gag(77-85) diminished HLA binding or increased off-rate
                    SLcNTVATL Gag(77-85) diminished HLA binding or increased off-rate
                    SLYNTiATL Gag(77-85) observed variant
                    SLfNaVATL Gag(77-85) diminished HLA binding or increased off-rate
                    SLfNTiAvL Gag(77-85) diminished HLA binding or increased off-rate
                    SLfNTiATL Gag(77-85) observed variant
                    SLYNTiAvL Gag(77-85) diminished HLA binding or increased off-rate
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLfNTVATL Gag(77-85) observed variant
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVAvL Gag(77-85) susceptible form
                    SLfNTVAvL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2 human epitope
                    SLYNTVATL Gag(77-85) A2, A68 human epitope
                    SLfNTiATL Gag(77-85) diminished response
                    SLYNTVATL Gag(77-85) B*57 human epitope
                    SLYNTVATL Gag(77-85) C*14 human epitope
                    SLYNTVATL Gag(77-85) H-2d human, mouse epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLFNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) epitope
                    SLYNTVAvL Gag(77-85) susceptible form
                    SLYNTiATL Gag(77-85) escape documented in this paper; susceptible form
                    SLYNTiAvL Gag(77-85) susceptible form
                    SLYNTVATL Gag(77-85) human epitope
                    pLYNTVATL Gag(77-85) HLA association; TCR related mutation
                    SLfNTVATL Gag(77-85) HLA association; TCR related mutation
                    SLYNTiATL Gag(77-85) HLA association; TCR related mutation
                    SLfNTVAvL Gag(77-85) HLA association; TCR related mutation
                    SLfNaVAvL Gag(77-85) HLA association; TCR related mutation
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATL Gag(77-85) human epitope
                    SLYNTVATLY Gag(77-86) A*02 human epitope
                    SLYNTVATLY Gag(77-86) A*02 human epitope
                    SLYNTVAvLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                    SLYNTiATLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                    SLYNTiAvLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                    SLfNTVATLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                    SLfNTiAvLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                    SLfNTVAvLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                    SLfNTiATLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                    SLYNTVATLY Gag(77-86) A*02:01 human epitope
                    SLYNTVATLY Gag(77-86) A2 human epitope
                    SLYNTVATLY Gag(77-86) A2 human epitope
                    SLFNTVATLY Gag(77-86) human epitope
                    SLYNTVATLY Gag(77-86) human epitope
                    SLYNTVATLY Gag(77-86) human epitope
                    SLYNIVATLWCVH Gag(77-89) human epitope
                    SLYNTVATLYCVHQR Gag(77-91) A*02:01, A*30:02 human epitope
                    SLfNTVATLYCVHQR Gag(77-91) susceptible form
                    SLYNTVATLYCVHQR Gag(77-91) A2, B44, B60 human epitope
                    SLYNTVATLYCVHQR Gag(77-91) H-2d transgenic mouse epitope
                    SLYNTVATLYCVHQR Gag(77-91) mouse epitope
                    SLYNTVATLYCVHQR Gag(77-91) human epitope
                    SLYNTVATLYCVHQRIEV Gag(77-94) human epitope
                    SLYNTVATLYCVHQRIEV Gag(77-94) human epitope
                     LYNTVATL Gag(78-85) A*02 human epitope
                     LYNTVATL Gag(78-85) A24 human epitope
                     LYNTVATL Gag(78-85) C*14 human epitope
                     LYNTVAVL Gag(78-85) C*14 human epitope
                     LYNTVATL Gag(78-85) C*14 human epitope
                     LYNTVATL Gag(78-85) C*14 human epitope
                     LYNTVATL Gag(78-85) C*14 human epitope
                     LYNTVATL Gag(78-85) C*14:02 human epitope
                     LYNTVATL Gag(78-85) C*14:02, C*14:03 human epitope
                     LYNTVATL Gag(78-85) H-2d mouse epitope
                     LYNTVATL Gag(78-85) human epitope
                     LYNTVATLY Gag(78-86) A*02 human epitope
                     LYNTVATLY Gag(78-86) A*29 human epitope
                     LYNTVATLY Gag(78-86) A*29 human epitope
                     LYNTVATLY Gag(78-86) A*29 human epitope
                     LYNTVAVLY Gag(78-86) A*29 human epitope
                     LYNTiAVLY Gag(78-86) observed variant
                     LfNTiAVLY Gag(78-86) observed variant
                     LfNTVAVLY Gag(78-86) observed variant
                     LYNTVATLY Gag(78-86) A*29, B*44 epitope
                     LYNTVATLY Gag(78-86) A29 human epitope
                     LYNTVATLY Gag(78-86) A*29:02 human epitope
                     LFNTVATLY Gag(78-86) A*29:02 human epitope
                     LYNTVATLY Gag(78-86) A*29:02 human epitope
                     LYNTIATLY Gag(78-86) A*29:02 human epitope
                     LYNTVATLY Gag(78-86) A*29:02, B*44:03 human epitope
                     LYNTVATLY Gag(78-86) A*29:02, B*44:03 human epitope
                     LYNTVATLY Gag(78-86) A*30 human epitope
                     LYNTVATLY Gag(78-86) B*44:03 human epitope
                     LYNTVATLY Gag(78-86) B*81 human epitope
                     LYNTVATLY Gag(78-86) C*14 human epitope
                     LYNTVATLY Gag(78-86) human epitope
                     LFNTVATLY Gag(78-86) human epitope
                     LyNTVATLY Gag(78-86) observed variant
                     LYNTVATLY Gag(78-86) human epitope
                     LYNTVATLY Gag(78-86) human epitope
                     LFNTVATLYCV Gag(78-88) A*02 human epitope
                     LYNTVATLYCVHQRI Gag(78-92) human epitope
                      YNIVATLWCVHQ Gag(79-90) human epitope
                      YNtVATLWCVHQ Gag(79-90) subtype-specific susceptible form
                      YNTVATLYCVHQRI Gag(79-92) human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health